Rachael R. Schulte, MD, MS, MSCI
Pediatric Hematology - Oncology
Employed Provider
Accepting New Patients
On This Page
About Me
Dr. Rachael R. Schulte specializes in Pediatric Hematology-Oncology for Riley Pediatric Cancer & Blood Disorders. Dr. Schulte earned her undergraduate degree right here in Indiana at Indiana State University. She then earned her medical degree, residency, and fellowship from Vanderbilt University School of Medicine, Nashville TN.
Dr. Schulte's primary location is Riley Pediatric Cancer & Blood Disorders, 575 Riley Hospital Dr, Indianapolis, IN 46202. She also sees patients at an office in Carmel.
Locations
Riley Pediatric Cancer & Blood Disorders
11700 N Meridian St
Suite C240
Carmel, IN, 46032
Get Directions 317.688.4673
Riley Pediatric Cancer & Blood Disorders
575 Riley Hospital Dr
Hematology/Oncology MSA
Indianapolis, IN, 46202
Get Directions 317.944.2143Specialties & Details
- Pediatric Hematology - Oncology
- Undergraduate: Indiana State University, Terre Haute, IN
- Masters degree: Vanderbilt University School of Medicine, Nashville, TN
- School of Medicine: Vanderbilt University School of Medicine, Nashville TN
- Residency: Vanderbilt University School of Medicine, Nashville TN
- Fellowship: Vanderbilt University School of Medicine, Nashville TN
- IU Health North Hospital
- Riley Physicians
- IU Health Medical Group
Insurance Accepted
Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.
Clinical Trials
Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.
A multi-center, open-label study to determine the dose and safety of oral asciminib in pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP), previously treated with one or more tyrosine kinase inhibitors
View DetailsDoctors at This Location
Pediatric Hematology - Oncology
4.9 out of 5 stars
(46 ratings)
Accepting New Patients
Pediatric Hematology - Oncology
4.8 out of 5 stars
(36 ratings)
Accepting New Patients
Pediatric Hematology - Oncology
4.8 out of 5 stars
(41 ratings)
Accepting New Patients
Pediatric Hematology - Oncology
4.6 out of 5 stars
(31 ratings)
Accepting New Patients
Pediatric Hematology - Oncology
3.9 out of 5 stars
(33 ratings)
Accepting New Patients